Premarket Mover: Outlook Therapeutics Inc (OTLK) Up 6.45%

Outlook Therapeutics Inc (OTLK) has gained Wednesday morning, with the stock gaining 6.45% in pre-market trading to 9.24. OTLK's short-term technical score of 43 indicates that the stock has traded less bullishly over the last month than 57% of stocks on the market. In the Biotechnology industry, which ranks 100 out of 146 industries, Outlook Therapeutics Inc ranks higher than 58% of stocks. Outlook Therapeutics Inc has fallen 1.03% over the past month, closing at $8.75 on February 28. During this period of time, the stock fell as low as $5.73 and as high as $11.72. OTLK has an average analyst recommendation of Strong Buy. The company has an average price target of $37.67.

OTLK has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on OTLK!

See Full OTLK Report

Outlook Therapeutics Inc has a Long-Term Technical rank of 42. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 58% of the market scoring higher. In the Biotechnology industry which is number 69 by this metric, OTLK ranks better than 69% of stocks.

Important Dates for Investors in OTLK:

-Outlook Therapeutics Inc is set to release earnings on 2024-05-20. Over the last 12 months, the company has reported EPS of $-0.20. -We do not have a set dividend date for Outlook Therapeutics Inc at this time. Click Here To Get The Full Report on Outlook Therapeutics Inc (OTLK)